Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;35(7):1073-1081.
doi: 10.1097/QAD.0000000000002859.

Assisted reproductive technology outcomes in women with a chronic viral disease

Mathilde Bourdon  1   2   3   4 , Alicia Garnier  1   2   4 , Chloé Maignien  1   2   4 , Louis Marcellin  1   2   3   4 , Emmanuel Dulioust  1   2   5 , Philippe Sogni  1   2   6 , Odile Launay  1   2   7 , Khaled Pocate Cheriet  1   2   3   5 , Catherine Patrat  1   2   5 , Charles Chapron  1   2   3   4 , Pietro Santulli  1   2   3   4
Affiliations

Assisted reproductive technology outcomes in women with a chronic viral disease

Mathilde Bourdon et al. AIDS. .

Abstract

Objective: The aim of this study was to evaluate the cumulative live birth rate in women undergoing in-vitro fertilization/intracytoplasmic-sperm-injection (IVF/ICSI) according to the type of chronic viral infection [HIV, hepatitis-B virus (HBV) and hepatitis-C virus (HCV)].

Design: A cohort study.

Setting: A tertiary-care university hospital.

Participants: Women with a chronic viral illness HIV, HBV or HCV- were followed until four IVF/ICSI cycles had been completed, until delivery or until discontinuation of the treatment before the completion of four cycles.

Main outcome measures: The primary outcome was the cumulative live birth rate after up to four IVF/ICSI cycles.

Results: A total of 235 women were allocated to the HIV-infected group (n = 101), the HBV-infected group (n = 114) and the HCV-infected group (n = 20). The cumulative live birth rate after four cycles was significantly lower in the HIV-infected women than in those with HBV [39.1%, 95% confidence interval (95% CI): 17.7-60.9 versus 52.8%, 95% CI: 41.6-65.5, respectively; P = 0.004]. Regarding the obstetrical outcomes, the mean birth weight was lower in the HIV-infected women than in those with HBV or HCV. Multivariate analysis indicated that the age, the anti-Müllerian hormone and the number of cycles performed were significantly associated with the chances of a live birth.

Conclusion: HIV-infected women had lower cumulative live birth rate than women with chronic hepatitis, and this was due to less favourable ovarian reserve parameters. These findings underscore the need to better inform practitioners and patients regarding fertility issues and the importance of early fertility assessment. However, larger studies are necessary to gain more in-depth knowledge of the direct impact of HIV on live birth rates.

PubMed Disclaimer

References

    1. Englert Y, Lesage B, Van Vooren J-P, Liesnard C, Place I, Vannin A-S, et al. Medically assisted reproduction in the presence of chronic viral diseases . Hum Reprod Update 2004; 10:149–162.
    1. Hanson BM, Dorais JA. Reproductive considerations in the setting of chronic viral illness . Am J Obstet Gynecol 2017; 217:4–10.
    1. Ninive C, Ferraretto X, Gricourt S, Llabador MA, Lepage J, Gauché-Cazalis C, et al. Prise en charge des couples porteurs du VIH en assistance médicale à la procréation: quels résultats et quelle stratégie en France en 2019?. [Assisted reproductive technologies in HIV patients: Which results and which strategy in France in 2019?] . Gynécol Obstét Fertil Sénol 2019; 47:362–369.
    1. Barnes A, Riche D, Mena L, Sison T, Barry L, Reddy R, et al. Efficacy and safety of intrauterine insemination and assisted reproductive technology in populations serodiscordant for human immunodeficiency virus: a systematic review and meta-analysis . Fertil Steril 2014; 102:424–434.
    1. Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion . Fertil Steril 2015; 104:e1–e8.